Cargando…

The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies

OBJECTIVE: To investigate the influence of chemotherapy (CT) on HBsAb titer in patients receiving CT due to hematological malignancy. MATERIALS AND METHODS: The data of 75 patients who received CT with the diagnosis of various hematological malignancies and who had serum HBsAb levels measured prior...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yağcı, Münci, Suyanı, Elif, Kızıl Çakar, Merih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563201/ https://www.ncbi.nlm.nih.gov/pubmed/26376591 http://dx.doi.org/10.4274/tjh.2013.0342

Ejemplares similares

A Randomized Study Comparing the Efficacy of Three Hepatitis B Vaccine Induction Regimens in Adult Patients with Hematological Malignancies
por: Özkurt, Zübeyde Nur, et al.
Publicado: (2016)

A Systemic Lupus Erythematosus Patient with Isolated Neutropenia and Diminished Expression of CD55 and CD59 Similar to Paroxysmal Nocturnal Hemoglobinuria
por: Yıldız, Abdülkerim, et al.
Publicado: (2014)

Prevalence of Monoclonal B Lymphocytosis in First-Degree Relatives of Chronic Lymphocytic Leukemia Patients in Turkey
por: Demirci, Taner, et al.
Publicado: (2015)

Assessment of antibody titers and immunity to Hepatitis B in children receiving chemotherapy
por: Shams Shahemabadi, A, et al.
Publicado: (2012)

Risk factors for ICU mortality in patients with hematological malignancies: a single-center, retrospective cohort study from Turkey
por: AYGENCEL, Gülbin, et al.
Publicado: (2022)

PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE
por: Karişmaz, Kadir, et al.
Publicado: (2023)

Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders
por: Mert, Duygu, et al.
Publicado: (2020)

Flow Cytometric Evaluation of Cell Cycle Regulators (Cyclins and Cyclin-Dependent Kinase Inhibitors) Expressed on Bone Marrow Cells in Patients with Chronic Myeloid Leukemia and Multiple Myeloma
por: Toprak, Selami K, et al.
Publicado: (2012)

A 80-Year-Old Woman with B-Cell Prolymphocytic Leukemia
por: Merdin, Alparslan, et al.
Publicado: (2017)

The outcome of COVID-19 in patients with hematological malignancy
por: Tığlıoğlu, Pınar, et al.
Publicado: (2021)

Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B
por: Li, Min-ran, et al.
Publicado: (2016)

Late Reactivation of Hepatitis B Virus after Chemotherapies for Hematological Malignancies: A Case Report and Review of the Literature
por: Yamada, Toshiki, et al.
Publicado: (2017)

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2018)

Hepatitis B virus prevalence and vaccine antibody titers in children HIV exposed but uninfected in Botswana
por: Baruti, Kabo, et al.
Publicado: (2020)

Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkin's lymphoma patients after rituximab chemotherapy
por: Tsutsumi, Y, et al.
Publicado: (2009)

Pralatrexate induced durable response in a relapsed/refractory peripheral T-cell lymphoma patient with a history of autologous stem cell transplantation: Case report of a patient followed-up over 3 years under pralatrexate treatment
por: Merdin, Alparslan, et al.
Publicado: (2019)

Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
por: Namdaroglu, Sinem, et al.
Publicado: (2019)

Bispecific Antibodies in the Treatment of Hematologic Malignancies
por: Duell, Johannes, et al.
Publicado: (2019)

Antiphospholipid Antibodies and Lipids in Hematological Malignancies
por: Barreno-Rocha, Sonia Guadalupe, et al.
Publicado: (2022)

Chemotherapy-related infectious complications in patients with Hematologic malignancies
por: Rusu, Raluca-Ana, et al.
Publicado: (2018)

Hepatitis B virus vaccination of voluntary blood donors and immunization status assessment by Anti-Hepatitis B Surface (HBs) antibody titer
por: Singh, R. P., et al.
Publicado: (2013)

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
por: Kakisaka, Keisuke, et al.
Publicado: (2019)

Early Direct Antiglobulin Test Negativity after Bendamustine and Rituximab Treatment in Chronic Lymphocytic Leukemia: Two Cases
por: Eren, Rafet, et al.
Publicado: (2018)

Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infection
por: Liu, Hung-Yin, et al.
Publicado: (2021)

Seroprevalence of Hepatitis A Virus in Pediatric Patients with Hematologic Malignancies after Chemotherapy and Hematopoietic Cell Transplantation
por: Moon, Ja Un, et al.
Publicado: (2019)

Coexistence of chronic lymphocytic leukemia and multiple myeloma, do the roots of these entities originate from the same place?
por: Merdin, Alparslan, et al.
Publicado: (2017)

An effective treatment in Erdheim Chester disease: vemurafenib: a case report
por: Bozan, Ersin, et al.
Publicado: (2023)

Comparison of post-remission strategies in acute myeloid leukemia: Autologous hematopoietic stem cell transplantation versus consolidation chemotherapy
por: Yegin, Zeynep Arzu, et al.
Publicado: (2020)

High Rate of Obstetric Complications in Patients With Essential Thrombocythemia
por: İskender, Dicle, et al.
Publicado: (2021)

Persistence of Protective Hepatitis B Surface Antibody Titers after Successful Double-Dose Hepatitis B Virus Rescue Vaccination in HIV-Infected Patients
por: Kim, Jong Hun, et al.
Publicado: (2012)

Baseline Quantitative Hepatitis B Core Antibody Titer Is a Predictor for Hepatitis B Virus Infection Recurrence After Orthotopic Liver Transplantation
por: Lou, Bin, et al.
Publicado: (2021)

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies
por: Kuter, David J.
Publicado: (2022)

Can treating critically-ill haematological malignancy patients in a separate intensive care unit decrease intensive care unit mortality?
por: AYGENCEL, Gülbin, et al.
Publicado: (2021)

The impact of repeated freeze‐thaw cycles on antiphospholipid antibody titer
por: Maelegheer, Karel, et al.
Publicado: (2018)

NF-κB in Hematological Malignancies
por: Imbert, Véronique, et al.
Publicado: (2017)

Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report
por: Han, Jing-Jing, et al.
Publicado: (2021)

Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014)

Antibody-Based Immunotherapeutic Strategies for the Treatment of Hematological Malignancies
por: Han, Yizhao, et al.
Publicado: (2020)

Bispecific Antibodies in Hematological Malignancies: A Scoping Review
por: Omer, Mohamed H., et al.
Publicado: (2023)

Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
por: Tavitian, Suzanne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_drja97hpibv0v7svg3hed4f4vk